About
We drive innovation and back entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck KGaA, Darmstadt, Germanys current and future businesses. We are the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Our mandate is to invest in innovative technologies and products with the potential to significantly impact Merck KGaA, Darmstadt, Germanys core business areas.
Key facts
- Website
- m-ventures.com
- Type
- Corporate Venture Capital
- Headquarters
- Germany
- Funds raised
- $485M
- Portfolio companies
- 8
- Stages
- SeedSeries ASeries BSeries B2Series C
- Cheque size
- $5M to $255M
- Sector focus
- 3D3D ImagingCMOSADASElectronics
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 2 Jan 2025 | Litmus | Series B | $30M |
| 7 Aug 2024 | Anjuna Security | Series B2 | $25M |
| 29 Apr 2024 | xMEMS | Series A | $21M |
| 3 Apr 2024 | Nucleai | Series B | $14M |
| 18 Mar 2024 | Celestial AI | Series C | $255M |
| 26 Jul 2023 | NeoLogic | Seed | $8M |
| 30 Mar 2023 | PxE Holographic Imaging | Seed | $5M |
| 1 Dec 2021 | Organox | Undisclosed round | $25M |
| 27 Jul 2021 | Wiliot | Series C | $200M |
| 25 Feb 2021 | Medisafe | Series C | $30M |
Add first review
Frequently asked
What companies has M Ventures invested in?
M Ventures has invested in Litmus, Anjuna Security, xMEMS, Nucleai, Celestial AI and 6 more.
AUM
$485M
PORTFOLIO
8
